ESI India Obesity Guidelines

Source: Indian Journal of Endocrinology and Metabolism (2024).

Key finding: Indian endocrinology guidelines for obesity management.

Part of GLP1Score's 20-study clinical evidence library — the peer-reviewed research powering our GLP-1 eligibility scoring engine.

Related Reading

Semaglutide in India — Complete Guide
Semaglutide Drug Monograph (dosing, contraindications)
Who Qualifies for Semaglutide in India
ADA Standards of Care in Diabetes — 2026
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6)
Higher-Dose Semaglutide (Up to 16 mg) for Type 2 Diabetes: A Phase 2 Dose-Ranging Study

Take the Free Eligibility Assessment → · Compare All 18+ Brands